TSMC to list NT$11.5 billion of green bonds: TPEx focustaiwan.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from focustaiwan.tw Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020.
HSINCHU, Taiwan, April 30, 2024 ￚ United Microelectronics Corporation , a leading global semiconductor foundry, today announced it placed in the top 5% in the 10th Corporate.
Financial Highlights:
Q124 consolidated revenue US$121.28 million, compared with US$99.99 million in the year-ago quarter
Q124 consolidated net income US$18.21 million; Basic and Fully diluted.
Foresee Pharmaceuticals Receives Positive Recommendation from DSMB to Continue the Casppian Study, a Phase 3 Clinical Trial of Leuprolide (FP-001) Injectable Emulsion for the Treatment of Central Precocious Puberty lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.